DK0586076T3 - Rekombinant adenovirus-vacciner - Google Patents
Rekombinant adenovirus-vaccinerInfo
- Publication number
- DK0586076T3 DK0586076T3 DK93305833T DK93305833T DK0586076T3 DK 0586076 T3 DK0586076 T3 DK 0586076T3 DK 93305833 T DK93305833 T DK 93305833T DK 93305833 T DK93305833 T DK 93305833T DK 0586076 T3 DK0586076 T3 DK 0586076T3
- Authority
- DK
- Denmark
- Prior art keywords
- recombinant adenoviruses
- antibodies
- recombinant adenovirus
- cell mediated
- mediated immunity
- Prior art date
Links
- 229940021704 adenovirus vaccine Drugs 0.000 title 1
- 241000701161 unidentified adenovirus Species 0.000 abstract 5
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000024932 T cell mediated immunity Effects 0.000 abstract 2
- 101710172711 Structural protein Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 210000002845 virion Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92649192A | 1992-08-07 | 1992-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0586076T3 true DK0586076T3 (da) | 2003-10-20 |
Family
ID=25453282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93305833T DK0586076T3 (da) | 1992-08-07 | 1993-07-23 | Rekombinant adenovirus-vacciner |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0586076B1 (da) |
JP (1) | JP4093597B2 (da) |
KR (1) | KR100347219B1 (da) |
AT (1) | ATE243755T1 (da) |
AU (2) | AU680826B2 (da) |
BR (1) | BR9303226A (da) |
CA (1) | CA2101463C (da) |
DE (1) | DE69333057T2 (da) |
DK (1) | DK0586076T3 (da) |
ES (1) | ES2201055T3 (da) |
FI (1) | FI114318B (da) |
HK (1) | HK1009978A1 (da) |
HU (2) | HU214364B (da) |
IL (1) | IL106508A (da) |
MX (1) | MX9304765A (da) |
NZ (1) | NZ248328A (da) |
PT (1) | PT586076E (da) |
ZA (1) | ZA935355B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG43029A1 (en) * | 1993-08-11 | 1997-10-17 | American Home Prod | Recombinant adenovirus vaccines |
IL113817A (en) * | 1994-06-30 | 2001-03-19 | Merck & Co Inc | Polynucleotide for vaccination against the umbilical cord virus |
FR2727867B1 (fr) * | 1994-12-13 | 1997-01-31 | Rhone Poulenc Rorer Sa | Transfert de genes dans les motoneurones medullaires au moyen de vecteurs adenoviraux |
EP0800403A2 (en) * | 1994-12-30 | 1997-10-15 | Chiron Corporation | Non-traumatic administration of gene delivery vehicles |
KR100464395B1 (ko) * | 1997-10-13 | 2005-02-28 | 삼성전자주식회사 | 반도체소자의비아홀형성방법 |
CA2378539A1 (en) | 1999-07-06 | 2001-01-11 | Merck & Co., Inc. | Adenovirus carrying gag gene hiv vaccine |
US6733993B2 (en) | 2000-09-15 | 2004-05-11 | Merck & Co., Inc. | Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications |
US8926987B2 (en) | 2004-11-18 | 2015-01-06 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Replication-competent adenoviral vectors |
US9132031B2 (en) | 2006-09-26 | 2015-09-15 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US20080287839A1 (en) | 2007-05-18 | 2008-11-20 | Juniper Medical, Inc. | Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator |
US8523927B2 (en) | 2007-07-13 | 2013-09-03 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
EP3488833A1 (en) | 2007-08-21 | 2019-05-29 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
US8603073B2 (en) | 2008-12-17 | 2013-12-10 | Zeltiq Aesthetics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
BRPI1014623B1 (pt) | 2009-04-30 | 2020-01-07 | Zeltiq Aesthetics, Inc. | Sistema para tratamento de celulas subcutâneas ricas em lipídeos em uma área alvo |
US9314368B2 (en) | 2010-01-25 | 2016-04-19 | Zeltiq Aesthetics, Inc. | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods |
US8676338B2 (en) | 2010-07-20 | 2014-03-18 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
US10722395B2 (en) | 2011-01-25 | 2020-07-28 | Zeltiq Aesthetics, Inc. | Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
US5585264A (en) * | 1988-07-15 | 1996-12-17 | University Of Saskatchewan | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides |
GB8919102D0 (en) * | 1989-08-22 | 1989-10-04 | Oxford Virology Ltd | A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus |
WO1992011028A1 (en) * | 1990-12-19 | 1992-07-09 | Epitope, Inc. | Hiv reverse transcriptase vaccine |
GB9114437D0 (en) * | 1991-07-03 | 1991-08-21 | Health Lab Service Board | Recombinant adenoviruses and the use thereof for detecting the presence in eukaryotic cells of the expression products of specific genes |
-
1993
- 1993-07-23 PT PT93305833T patent/PT586076E/pt unknown
- 1993-07-23 EP EP93305833A patent/EP0586076B1/en not_active Expired - Lifetime
- 1993-07-23 ZA ZA935355A patent/ZA935355B/xx unknown
- 1993-07-23 DK DK93305833T patent/DK0586076T3/da active
- 1993-07-23 ES ES93305833T patent/ES2201055T3/es not_active Expired - Lifetime
- 1993-07-23 DE DE69333057T patent/DE69333057T2/de not_active Expired - Fee Related
- 1993-07-23 AT AT93305833T patent/ATE243755T1/de not_active IP Right Cessation
- 1993-07-28 IL IL106508A patent/IL106508A/en not_active IP Right Cessation
- 1993-07-28 CA CA002101463A patent/CA2101463C/en not_active Expired - Fee Related
- 1993-07-30 BR BR9303226A patent/BR9303226A/pt not_active Application Discontinuation
- 1993-08-04 NZ NZ248328A patent/NZ248328A/en not_active IP Right Cessation
- 1993-08-04 JP JP19341093A patent/JP4093597B2/ja not_active Expired - Fee Related
- 1993-08-05 MX MX9304765A patent/MX9304765A/es not_active IP Right Cessation
- 1993-08-06 KR KR1019930015236A patent/KR100347219B1/ko not_active IP Right Cessation
- 1993-08-06 AU AU44465/93A patent/AU680826B2/en not_active Ceased
- 1993-08-06 FI FI933495A patent/FI114318B/fi active IP Right Grant
- 1993-08-06 HU HU9302285A patent/HU214364B/hu not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00643P patent/HU211691A9/hu unknown
-
1997
- 1997-08-18 AU AU34227/97A patent/AU715190B2/en not_active Ceased
-
1998
- 1998-09-19 HK HK98110746A patent/HK1009978A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX9304765A (es) | 1995-01-31 |
FI933495A0 (fi) | 1993-08-06 |
AU680826B2 (en) | 1997-08-14 |
AU4446593A (en) | 1994-02-10 |
ES2201055T3 (es) | 2004-03-16 |
IL106508A (en) | 1998-02-22 |
EP0586076B1 (en) | 2003-06-25 |
PT586076E (pt) | 2003-11-28 |
HK1009978A1 (en) | 1999-06-11 |
DE69333057T2 (de) | 2004-07-08 |
AU3422797A (en) | 1997-11-20 |
EP0586076A3 (en) | 1994-04-20 |
ZA935355B (en) | 1995-01-23 |
ATE243755T1 (de) | 2003-07-15 |
FI114318B (fi) | 2004-09-30 |
KR100347219B1 (ko) | 2003-02-25 |
JPH06165689A (ja) | 1994-06-14 |
IL106508A0 (en) | 1993-11-15 |
NZ248328A (en) | 1997-05-26 |
AU715190B2 (en) | 2000-01-20 |
HU211691A9 (en) | 1995-12-28 |
HUT67302A (en) | 1995-03-28 |
JP4093597B2 (ja) | 2008-06-04 |
KR940003566A (ko) | 1994-03-12 |
EP0586076A2 (en) | 1994-03-09 |
CA2101463C (en) | 2007-03-13 |
CA2101463A1 (en) | 1994-02-08 |
HU9302285D0 (en) | 1993-11-29 |
BR9303226A (pt) | 1994-03-08 |
DE69333057D1 (de) | 2003-07-31 |
HU214364B (hu) | 1998-03-30 |
FI933495A (fi) | 1994-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69333057D1 (de) | Rekombinente Adenoviren-Impfstoffe | |
AU576907B2 (en) | Oral vaccines comprising live recombinant adenoviruses | |
FI113621B (fi) | Menetelmä rekombinanttiadenovirusrokotteiden valmistamiseksi | |
AU2403188A (en) | Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
MX9201970A (es) | Proteinas superficiales del virus de la hepatitis b con un contenido reducido del carbohidrato huesped. |